A Study of CT-388 in Otherwise Healthy Overweight and Obese Adults and Patients With Type 2 Diabetes Mellitus

NCT04838405 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

129

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes

Interventions

DRUG: CT-388
DRUG: Placebo

Sponsor

Carmot Therapeutics, Inc.

Collaborators

[object Object]